Does Marijuana Rescheduling Really Help Tilray's Stock?
Earlier this year, the U.S. government announced it would reclassify certain medical cannabis products from Schedule I to Schedule III substances.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.